結構性心臟封堵器市場規模、佔有率和成長分析：按器械類型、材料、植入方式、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球結構性心臟封堵器市場價值為 40 億美元，預計到 2025 年將成長至 42.8 億美元，到 2033 年將成長至 73.6 億美元，在預測期（2026-2033 年）內複合年成長率為 7.0%。

全球結構性心臟封堵器設備市場專注於創新技術，旨在封鎖先天性心臟疾病，例如心房中膈缺損症和左心耳漏。這些器械對於降低中風風險和減少開胸手術的需求至關重要，並正受到廣泛關注，尤其是在人口老化和心房顫動盛行率不斷上升的背景下。器械設計的進步、輸送系統的改進以及有利於醫療機構經濟效益的法規結構，共同推動了市場成長。此外，人工智慧驅動的自動化成像技術的引入，正在革新手術的精確度和效率，從而實現更完善的術前規劃和手術執行。這種技術協同作用不僅促進了製造商和成像公司之間的合作，還透過符合安全標準的本地化封鎖解決方案，推動了新興市場對這些器械的接受度。

全球結構性心臟封堵器市場成長要素

臨床實務中結構性心臟封堵裝置的日益普及源於其相較於傳統外科手術的諸多優勢，包括減輕手術帶來的身體負擔、縮短住院時間以及降低併發症發生率。這一趨勢促使醫院積極採用這些先進技術，也促使製造商拓展產品線並加強培訓計畫。隨著醫療專業人員對這些裝置的有效性越來越有信心，患者轉診也擴大轉向經經皮介入治療，從而推動了不同患者群體和地區的市場成長。最終，對提高病患安全性和治療效果的重視顯著提升了對尖端封堵解決方案的需求。

全球結構性心臟封堵裝置市場的限制因素

先進閉塞系統的高成本對許多醫療機構構成重大障礙，尤其是在資源匱乏的環境中。醫院經常面臨如何在預算緊張和其他緊迫的治療需求之間取得平衡，同時又要證明其成本合理性的挑戰，這往往導致新系統的採用延遲或選擇更經濟實惠的方案。此外，各地區的報銷政策通常較為嚴格，進一步限制了患者的就醫途徑，並阻礙了潛在的市場成長。因此，消費者對成本的高度敏感阻礙了市場發展，迫使製造商在尖端創新與成本效益之間尋求平衡，以期在瞬息萬變的醫療保健市場中獲得更廣泛的認可。

全球結構性心臟封堵器市場趨勢

全球結構性心臟封堵器械市場正呈現微創技術發展趨勢，醫療專業人員越來越傾向於選擇基於導管的解決方案，以最大限度地減少手術負擔並促進患者更快康復。這種日益成長的需求促使製造商不斷創新器械設計，專注於改進器械外形並增強輸送系統，使其具備無縫整合的成像功能。這些進步使得透過更小的網路基地台來治療複雜的解剖結構成為可能，從而增強了醫生的信心並擴大了轉診模式。這一趨勢促進了多學科心臟醫療團隊之間的協作，並推動了這些先進療法在社區醫院的更廣泛應用，同時兼顧了臨床療效和病人安全。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球結構性心臟封堵器市場規模：依器械類型分類

• 左心耳封堵裝置
• 卵圓孔未閉合
• 心房中膈缺損症封堵裝置
• 室間隔缺損封堵器

全球結構性心臟封堵器市場規模：依材料分類

• 鎳鈦諾
• 鈷鉻合金
• 其他材料

全球結構性心臟阻塞裝置市場規模：依輸送方式分類

• 經導管
• 外科

全球結構性心臟阻塞裝置市場規模：依應用分類

• 預防中風
• 先天性心臟病閉合
• 在結構性心臟病治療的其他應用

全球結構性心臟封堵器市場規模：依最終用戶分類

• 醫院
• 專業心臟病中心
• 門診手術中心

全球結構性心臟封堵器市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc
• Edwards Lifesciences Corporation
• LivaNova PLC
• WL Gore & Associates, Inc.
• Occlutech GmbH
• Lifetech Scientific Corporation
• MicroPort Scientific Corporation
• Cardia, Inc.
• ArtVentive Medical Group, Inc.
• Endologix LLC
• Terumo Corporation
• Meril Life Sciences Pvt. Ltd.
• JenaValve Technology GmbH
• Venus Medtech
• AtriCure, Inc.
• Sahajanand Medical Technologies Pvt. Ltd.
• Shape Memory Medical Inc.
• Occlutech

結論與建議

Global Structural Heart Occlusion Devices Market size was valued at USD 4.0 Billion in 2024 and is poised to grow from USD 4.28 Billion in 2025 to USD 7.36 Billion by 2033, growing at a CAGR of 7.0% during the forecast period (2026-2033).

The global market for structural heart occlusion devices focuses on innovative technologies aimed at sealing congenital and cardiac defects such as atrial septal defects and left-atrial appendage leaks. These devices are crucial for mitigating stroke risks and minimizing the need for open-heart surgery, particularly appealing to an aging demographic and the increasing prevalence of atrial fibrillation. Market growth is bolstered by advancements in device design, improved delivery systems, and supportive regulatory frameworks, which enhance financial viability for healthcare providers. Additionally, the integration of AI-driven imaging automation is revolutionizing procedural accuracy and efficiency, enabling better planning and operational execution. This technological synergy is not only fostering partnerships between manufacturers and imaging companies but also encouraging adoption in emerging markets with localized occlusion solutions that meet safety standards.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Structural Heart Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Structural Heart Occlusion Devices Market Segments Analysis

Global structural heart occlusion devices market is segmented by device type, material, delivery approach, application, end user and region. Based on device type, the market is segmented into Left Atrial Appendage Occlusion Devices, Patent Foramen Ovale Closure Devices, Atrial Septal Defect Closure Devices and Ventricular Septal Defect Closure Devices. Based on material, the market is segmented into Nitinol, Cobalt-Chromium and Other Materials. Based on delivery approach, the market is segmented into Transcatheter and Surgical. Based on application, the market is segmented into Stroke Prevention, Congenital Heart Defect Closure and Other Structural Heart Applications. Based on end user, the market is segmented into Hospitals, Specialty Cardiac Centers and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Structural Heart Occlusion Devices Market

The growing preference for structural heart occlusion devices within the clinical community stems from their ability to minimize procedural trauma, decrease hospital stays, and reduce complication rates when compared to traditional surgical methods. This inclination encourages hospitals to embrace these advanced technologies, leading manufacturers to broaden their product offerings and enhance training initiatives. As healthcare professionals become more confident in the efficacy of these devices, referral practices increasingly pivot towards percutaneous interventions, thereby driving market growth across varied patient demographics and locations. Ultimately, the focus on patient safety and improved outcomes significantly propels the demand for cutting-edge occlusion solutions.

Restraints in the Global Structural Heart Occlusion Devices Market

The elevated costs associated with advanced occlusion systems act as a significant barrier for numerous healthcare providers, especially in settings with limited resources. Hospitals frequently face the challenge of justifying their expenses within tight budgets and against other pressing therapeutic needs, which can result in postponed implementation or a tendency to opt for more affordable options. Additionally, reimbursement policies in various areas are often restrictive, further limiting patient access and curtailing potential market growth. As a result, the cost-conscious nature of buyers hinders market development, compelling manufacturers to strike a balance between cutting-edge innovation and cost-effectiveness to gain wider acceptance in the dynamic healthcare environment.

Market Trends of the Global Structural Heart Occlusion Devices Market

The Global Structural Heart Occlusion Devices market is witnessing a significant trend towards minimally invasive techniques, as healthcare professionals increasingly prefer catheter-based solutions that minimize procedural trauma and promote quicker patient recovery. This growing demand compels manufacturers to innovate their device designs, focusing on improved profiles and enhanced delivery systems that seamlessly incorporate imaging capabilities. Such advancements facilitate the treatment of complex anatomical structures through smaller access points, building operator confidence and leading to expanded referral patterns. This trend is fostering partnerships among multidisciplinary heart teams and encouraging broader adoption of these advanced therapeutic options across community hospitals, prioritizing both clinical efficacy and patient safety.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Structural Heart Occlusion Devices Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Left Atrial Appendage Occlusion Devices
• Patent Foramen Ovale Closure Devices
• Atrial Septal Defect Closure Devices
• Ventricular Septal Defect Closure Devices

Global Structural Heart Occlusion Devices Market Size by Material & CAGR (2026-2033)

• Market Overview
• Nitinol
• Cobalt-Chromium
• Other Materials

Global Structural Heart Occlusion Devices Market Size by Delivery Approach & CAGR (2026-2033)

• Market Overview
• Transcatheter
• Surgical

Global Structural Heart Occlusion Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Stroke Prevention
• Congenital Heart Defect Closure
• Other Structural Heart Applications

Global Structural Heart Occlusion Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Cardiac Centers
• Ambulatory Surgical Centers

Global Structural Heart Occlusion Devices Market Size & CAGR (2026-2033)

• North America (Device Type, Material, Delivery Approach, Application, End User)
  • US
  • Canada
• Europe (Device Type, Material, Delivery Approach, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Material, Delivery Approach, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Material, Delivery Approach, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Material, Delivery Approach, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Occlutech GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardia, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArtVentive Medical Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sahajanand Medical Technologies Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shape Memory Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Occlutech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations